Compare BIO & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | LNC |
|---|---|---|
| Founded | 1952 | 1905 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Life Insurance |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.5B |
| IPO Year | N/A | N/A |
| Metric | BIO | LNC |
|---|---|---|
| Price | $265.66 | $33.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 14 |
| Target Price | ★ $358.50 | $44.86 |
| AVG Volume (30 Days) | 237.8K | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $11.23 |
| Revenue Next Year | $3.05 | $3.77 |
| P/E Ratio | $9.72 | ★ $7.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $27.58 |
| 52 Week High | $343.12 | $46.82 |
| Indicator | BIO | LNC |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 38.78 |
| Support Level | $239.33 | $32.26 |
| Resistance Level | $289.61 | $42.28 |
| Average True Range (ATR) | 7.68 | 1.10 |
| MACD | 0.48 | 0.18 |
| Stochastic Oscillator | 24.82 | 51.61 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.